64Cu-DOTA-Rituximab PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-DOTA-Rituximab PET/CT, covering 2016-10-04 to 2016-10-04. Get the full timeline:
Most recent: Clinical Trial Update: Assessing Response to Treatment in Non-Hodgkin's Lymphoma Patients Using 64Cu-DOTA-Rituximab PET/CT [NA]